Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Evidence base is improved for effective prevention, treatment and harm reduction of synthetic drugs and stimulants in Europe; Relevant European security practitioners, notably Police Authorities, Civil Society Organisations and Non-Governmental Organisations, are equipped with skills, tools and technology aimed at reducing the violence and offences associated with use and marketing of these substances, as well as at combatting drug trafficking from its origin to destination (i.e., through the entire supply chain); Increased understanding of relevant European security practitioners and policymakers regarding the influence of external drivers of change of societal, technological, legal, economic and ethical nature to the availability and use of different types of synthetic drugs and drug markets. Scope: This topic asks for proposals that seek to develop effective and evidence-based responses to the growing prevalence of synthetic drugs and stimulants, such as cocaine and crack cocaine, within the EU. As these substances increasingly influence the drug landscape, the urgent need for enhanced understanding and strategies in their prevention, treatment, and harm reduction has never been clearer. Amongst other, there is also a lack of pharmacological data for the emerging drugs, needed to do proper risk assessments and interventions of these drugs in Europe. Key focus areas inclu…bron

De eisen uit de regeling. Uw situatie bepaalt of u voldoet; dit is geen beschikking.

• Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in EuropeEU-portaal (SEDIA) · ec.europa.eu7 jul 2026
  Toon brontekst

  Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe
  
  Topic: HORIZON-CL3-2027-01-FCT-05
  Call: HORIZON-CL3-2027-01 — Civil Security for Society 2027
  Programma: Horizon Europe (2021 - 2027)
  
  == Beschrijving ==
  Expected Outcome:
  Project results are expected to contribute to all of the following expected outcomes:
  Evidence base is improved for effective prevention, treatment and harm reduction of synthetic drugs and stimulants in Europe;
  Relevant European security practitioners, notably Police Authorities, Civil Society Organisations and Non-Governmental Organisations, are equipped with skills, tools and technology aimed at reducing the violence and offences associated with use and marketing of these substances, as well as at combatting drug trafficking from its origin to destination (i.e., through the entire supply chain);
  Increased understanding of relevant European security practitioners and policymakers regarding the influence of external drivers of change of societal, technological, legal, economic and ethical nature to the availability and use of different types of synthetic drugs and drug markets.
  Scope:
  This topic asks for proposals that seek to develop effective and evidence-based responses to the growing prevalence of synthetic drugs and stimulants, such as cocaine and crack cocaine, within the EU. As these substances increasingly influence the drug landscape, the urgent need for enhanced understanding and strategies in their prevention, treatment, and harm reduction has never been clearer. Amongst other, there is also a lack of pharmacological data for the emerging drugs, needed to do proper risk assessments and interventions of these drugs in Europe. Key focus areas include:
  Evidence-based approaches, strengthening the evidence base to inform effective prevention strategies, treatment modalities, and harm reduction practices targeted at synthetic drugs and stimulants. This includes identifying best practices in current interventions and evaluating their efficacy.
  Reducing violence and offending exploring strategies to mitigate the violence and criminal behaviour associated with the use and marketing of synthetic drugs. This involves understanding the socio-economic and cultural factors, including the gender, age, or other social factors, that contribute to these phenomena and proposing targeted interventions.
  Improving technologies and tools to combat drug trafficking from its origin to destination (i.e., through the entire supply chain).
  External drivers of change, analysing the impact of geopolitical situations, legal frameworks, and societal factors on the availability and consumption of various drugs, and addressing how international crises affect organised crime and drug markets in the EU. This includes investigating the repercussions of global developments on local drug dynamics and identifying adaptive response strategies.
  In light of the underdeveloped evidence base surrounding synthetic drugs, proposals should aim to foster collaboration among researchers, policymakers, and security practitioners to create a comprehensive and effective response to this pressing issue in Europe, previous research, including but not limited to research by other Framework Programmes’ projects. Coordination among the successful proposals from this topic should be envisaged to avoid duplication and to exploit complementarities as well as opportunities for increased impact. To ensure the active involvement of and timely feedback from relevant security practitioners, proposals should plan a mid-term deliverable consisting in the assessment of the project’s mid-term outcomes, performed by the practitioners involved in the project.
  Activities proposed within this topic should address, in a balanced way, both technological and societal dimensions of the issue under consideration. The proposals funded under this topic are expected to engage with the Europol Innovation Lab during the lifetime of the project, including validating the outcomes, with the aim of facilitating future uptake of innovations for the law enforcement community. Similarly, the proposals funded under this topic are expected to engage with the EU Drugs Agency during the lifetime of the project, including validating the outcomes. Finally, proposals are expected to address all applicable considerations expressed in the Introduction of the Fighting Crime and Terrorism Destination.
  null
  Activities are expected to achieve TRL 6-8 by the end of the project – see General Annex B.
  
  == Voorwaarden (topic conditions) ==
  ">
  General conditions
  1. Admissibility Conditions: Proposal page limit and layout
  described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
  Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
  DELETE ME Please add hyperlinks as embedded links where needed (underscored text). Send the call document through the document publication form to receive the hyperlink within 2 business days max. DELETE ME
  2. Eligible Countries
  described in Annex B of the Work Programme General Annexes.
  A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
  3. Other Eligible Conditions
  The following additional eligibility criteria apply:
  This topic requires the active involvement, as beneficiaries, of at least 3 Police Authorities[[In the context of this Destination, ‘Police Authorities’ means public authorities explicitly designated by national law, or other entities legally mandated by the competent national authority, for the prevention, detection and/or investigation of terrorist offences or other criminal offences, specifically excluding police academies, forensic institutes, training facilities as well as border and customs authorities.]] and at least 2 Civil Society Organisations (or Non-Governmental Organisations) from at least 3 different EU Member States or Associated Countries. For these participants, applicants must fill in the table “Information about security practitioners” in the application form with all the requested information, following the template provided in the submission IT tool.
  If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
  described in Annex B of the Work Programme General Annexes.
  4. Financial and operational capacity and exclusion
  described in Annex C of the Work Programme General Annexes.
  5a. Evaluation and award: Award criteria, scoring and thresholds
  are described in Annex D of the Work Programme General Annexes.
  5b. Evaluation and award: Submission and evaluation processes
  are described in Annex F of the Work Programme General Annexes and the Online Manual.
  5c. Evaluation and award: Indicative timeline for evaluation and grant agreement
  described in Annex F of the Work Programme General Annexes.
  6. Legal and financial set-up of the grants
  The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.
  Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].
  described in Annex G of the Work Programme General Annexes.
  Specific conditions
  described in the [specific topic of the Work Programme]
  Some activities resulting from this topic may involve using classified background and/or producing of security sensitive results (EUCI and SEN). Please refer to the related provisions in section B Security — EU classified and sensitive information of the General Annexes.
  Application and evaluation forms and model grant agreement (MGA):
  Application form templates — the application form specific to this call is available in the Submission System
  Standard application form (HE RIA, IA)
  Standard application form (HE RIA IA Stage 1)
  Standard application form (HE RIA IA Stage 1 BLIND)
  Standard application form (HE CSA)
  Standard application form (HE CSA Stage 1)
  Standard application form (HE CSA Stage 1 BLIND)
  Standard application form (HE RI)
  Standard application form (HE PCP)
  Standard application form (HE PPI)
  Standard application form (HE COFUND)
  Standard application form (HE FPA)
  Standard application form (HE MSCA PF)
  Standard application form (HE MSCA DN)
  Standard application form (HE MSCA SE)
  Standard application form (HE MSCA COFUND)
  Standard application form (HE MSCA COFUND CE)
  Standard application form (HE ERC STG)
  Standard application form (HE ERC COG)
  Standard application form (HE ERC ADG)
  Standard application form (HE ERC POC)
  Standard application form (HE ERC SYG)
  Standard application form (HE EIC PATHFINDER CHALLENGES)
  Standard application form (HE EIC PATHFINDER OPEN)
  Standard application form (HE EIC TRANSITION)
  Standard application form (HE EIC STEP)
  Standard application form (HE EIC Accelerator stage 2 - full proposal)
  Standard application form (HE EIC Accelerator stage 1 - short proposal)
  Evaluation form templates — will be used with the necessary adaptations
  Standard evaluation form (HE RIA, IA)
  Standard evaluation form (HE CSA)
  Standard evaluation form (HE RIA, IA and CSA Stage 1)
  Standard evaluation form (HE RIA, IA and CSA Stage 1 BLIND)
  Standard evaluation form (HE PCP PPI)
  Standard evaluation form (HE COFUND)
  Standard evaluation form (HE FPA)
  Standard evaluation form (HE MSCA)
  Standard evaluation form (HE EIC PATHFINDER CHALLENGES)
  Standard evaluation form (HE EIC PATHFINDER OPEN)
  Standard evaluation form (HE EIC TRANSITION)
  Standard evaluation form (HE EIC Accelerator stage 1 - short proposal)
  Standard evaluation form (HE EIC Accelerator stage 2 - full proposal)
  Guidance
  HE Programme Guide
  Model Grant Agreements (MGA)
  HE MGA
  HE Unit MGA
  Lump Sum MGA
  Operating Grants MGA
  Framework Partnership Agreement FPA
  Call-specific instructions
  Detailed budget table (HE LS)
  Information on financial support to third parties (HE)
  Information on clinical studies (HE)
  Guidance: "Lump sums - what do I need to know?"
  Additional documents:
  HE Main Work Programme 2025 – 1. General Introduction
  HE Main Work Programme 2023–2025 – 2. Marie Skłodowska-Curie Actions
  HE Main Work Programme 2025 – 3. Research Infrastructures
  HE Main Work Programme 2025 – 4. Health
  HE Main Work Programme 2025 – 5. Culture, creativity and inclusive society
  HE Main Work Programme 2025 – 6. Civil Security for Society
  HE Main Work Programme 2025 – 7. Digital, Industry and Space
  HE Main Work Programme 2025 – 8. Climate, Energy and Mobility
  HE Main Work Programme 2025 – 9. Food, Bioeconomy, Natural Resources, Agriculture and Environment
  HE Main Work Programme 2025 – 10. European Innovation Ecosystems (EIE)
  HE Main Work Programme 2025 – 11. Widening participation and strengthening the European Research Area
  HE Main Work Programme 2025 – 12. Missions
  HE Main Work Programme 2025 – 13. New European Bauhaus Facility (NEB)
  HE Main Work Programme 2025 – 14. General Annexes
  HE Main Work Programme 2023–2025 – 13. General Annexes
  EIC Work Programme 2025
  ERC Work Programme 2026
  HE Programme Guide
  HE Framework Programme 202
  
  […tekst ingekort]